New drug tested to calm severe schizophrenia episodes

NCT ID NCT06963034

Recruiting now Disease control Sponsor: Neurocrine Biosciences Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational medicine called NBI-1117568 can help reduce the severe symptoms of schizophrenia in adults who need to be hospitalized. Researchers will compare the drug to a placebo (an inactive substance) over 5 weeks. The goal is to see if the medicine safely improves symptoms better than the placebo for people experiencing a serious flare-up of their condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Neurocrine Clinical Site
RECRUITING

Bryant, Arkansas, 72022, United States
Neurocrine Clinical Site
RECRUITING

Little Rock, Arkansas, 72211, United States
Neurocrine Clinical Site
RECRUITING

Anaheim, California, 92805, United States
Neurocrine Clinical Site
RECRUITING

Pico Rivera, California, 90660, United States
Neurocrine Clinical Site
RECRUITING

San Diego, California, 92123, United States
Neurocrine Clinical Site
RECRUITING

Sherman Oaks, California, 91403, United States
Neurocrine Clinical Site
RECRUITING

Torrance, California, 90504, United States
Neurocrine Clinical Site
RECRUITING

Hollywood, Florida, 33024, United States
Neurocrine Clinical Site
RECRUITING

Miami Lakes, Florida, 33016, United States
Neurocrine Clinical Site
RECRUITING

Atlanta, Georgia, 30331, United States
Neurocrine Clinical Site
RECRUITING

Decatur, Georgia, 30030, United States
Neurocrine Clinical Site
RECRUITING

Snellville, Georgia, 30078, United States
Neurocrine Clinical Site
RECRUITING

Chicago, Illinois, 60640, United States
Neurocrine Clinical Site
RECRUITING

Gaithersburg, Maryland, 20877, United States
Neurocrine Clinical Site
RECRUITING

Watertown, Massachusetts, 02472, United States
Neurocrine Clinical Site
RECRUITING

Marlton, New Jersey, 08053, United States
Neurocrine Clinical Site
RECRUITING

Staten Island, New York, 10314, United States
Neurocrine Clinical Site
RECRUITING

The Bronx, New York, 10461, United States
Neurocrine Clinical Site
RECRUITING

Austin, Texas, 78754, United States
Neurocrine Clinical Site
RECRUITING

DeSoto, Texas, 75115, United States
Neurocrine Clinical Site
RECRUITING

Houston, Texas, 77043, United States

Conditions

Explore the condition pages connected to this study.

SCHIZOPHRENIA